Management of Skin Toxicity Associated with Cetuximab Treatment in Combination with Chemotherapy or Radiotherapy

BACKGROUND. Cetuximab was demonstrated by clinical trials to improve response rate and survival of patients with metastatic and nonresectable colorectal cancer or carcinoma of the head and neck. Appropriate management of skin toxicity associated with epidermal growth factor receptor inhibitor (EGFR-...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Pinto, Carmine, Barone, Carlo Antonio, Girolomoni, Giampiero, Russi, Elvio Grazioso, Merlano, Marco Carlo, Ferrari, Daris, Maiello, Evaristo
Natura: Artigo
Lingua:Inglês
Pubblicazione: AlphaMed Press 2011
Soggetti:
Symptom Management and Supportive Care
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228080/
https://ncbi.nlm.nih.gov/pubmed/21273511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0298
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi